Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Airway Therapeutics LLC
DescriptionRecombinant surfactant protein D (SB-D)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationBronchopulmonary dysplasia (BPD)
Indication DetailsTreat bronchopulmonary dysplasia (BPD)
Regulatory Designation U.S. - Orphan Drug (Treat bronchopulmonary dysplasia (BPD));
EU - Orphan Drug (Treat bronchopulmonary dysplasia (BPD))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today